Miscarriage Clinical Trials 2023

What are the top hospitals conducting miscarriage research?

Miscarriage is a heartbreaking experience that affects many individuals and couples around the world. While it remains a complex and often misunderstood condition, hospitals are continuously working towards finding new insights and potential interventions. Reprogenetics, located in Livingston, stands out as one of the top institutions dedicated to researching miscarriage. Although they currently have only one active clinical trial focused on this topic, their commitment to advancing knowledge in this field is evident. With zero completed trials specifically targeting miscarriage thus far, Reprogenetics represents a fresh perspective in exploring potential solutions for those who have experienced such heart-wrenching losses. This hospital's dedication to understanding miscarriage highlights the ongoing quest for answers and brings hope to those seeking support and guidance through this difficult journey

Which are the best cities for miscarriage clinical trials?

When it comes to clinical trials focused on miscarriage, one city stands out as a leader in research and development. Livingston, New jersey is currently hosting 1 active trial investigating Next Generation Sequencing after Blastocyst biopsy and other potential interventions. This dedicated effort offers individuals struggling with miscarriage an opportunity to participate in cutting-edge research that aims to improve understanding and treatment options for this heartbreaking experience.

Which are the top treatments for miscarriage being explored in clinical trials?

Clinical trials are actively investigating several potential treatments for miscarriage. Among the top contenders are:

• Progesterone supplementation: A hormone therapy aimed at supporting pregnancy and reducing the risk of miscarriage.
• Intravenous immunoglobulin (IVIG) therapy: An infusion of antibodies that may help modulate immune responses and promote successful pregnancies.
• Tissue plasminogen activator (tPA): An enzyme that could potentially dissolve blood clots in the placenta, improving blood flow and preventing miscarriages.

These therapies show promising prospects in ongoing clinical trials, offering hope to couples navigating through this difficult experience.

What are the most recent clinical trials for miscarriage?

Recent clinical trials have focused on finding effective interventions for miscarriage. One notable study involves the use of next-generation sequencing following blastocyst biopsy, which has shown promise in determining genetic abnormalities that may contribute to miscarriages. This Phase 2 trial, available since September 1st, 2013, aims to enhance our understanding of the underlying causes of miscarriage and potentially improve outcomes for couples experiencing this heartbreaking loss.

What miscarriage clinical trials were recently completed?

Recent clinical trials have made significant strides in the field of miscarriage research. In May 2022, the University of North carolina, Chapel Hill concluded a trial investigating the potential benefits of Ulipristal Acetate Tablets. Additionally, Stanford University conducted a pioneering study in August 2017 that explored Uterine ERA and microbiome testing. These studies contribute valuable insights into understanding and addressing miscarriage, offering hope for improved treatments and outcomes for affected individuals.